The Department is not aware of issues affecting the availability of losartan, furosemide or nicorandil tablets and can confirm that supplies of these three medicines are currently available. We are aware that there was a short-term supply issue affecting furosemide 20mg and 40mg towards the end of 2018 due to manufacturing delays, but this issue has now been resolved and supplies remain available.<\/p>
<\/p>
When community pharmacies cannot purchase a medicine at or below the reimbursement price listed in the Drug Tariff, the Pharmaceutical Services Negotiating Committee (the representative body of pharmacies), drawing on reports they receive from pharmacy contractors, can request the Department to consider setting a concessionary price.<\/p>
<\/p>
When considering whether to grant a concessionary price, the Department uses market data from suppliers, i.e. manufacturers and wholesalers on prices and stock levels intended for retail pharmacy businesses in England. If granted, a concessionary price applies only to prescriptions dispensed for the month for which it was granted.<\/p>
<\/p>
From September 2018 onwards, the trends for these generic medicines that have been granted concessionary prices can be seen in the attached tables.<\/p>
<\/p>
It should be noted that as concessionary prices for February are still in process, no prices have been published yet. More information on the list of concessionary prices granted for each month can be found at the following link:<\/p>
<\/p>
https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff/drug-tariff-updates<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/1061232/answer/attachment/1", "fileName" : {"_value" : "PQ221587 attached tables.docx"}
, "title" : "PQ221587 attached tables"}
, "dateOfAnswer" : {"_value" : "2019-02-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-19T17:22:23.543Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-02-14", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of trends in the level of the (a) availability of (i) Lossartin, (ii) Furosemide and (iii) Nicarindil and (b) prices beyond the NHS tariff that community pharmacies have been charged by the suppliers of those products since September 2018.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/301", "label" : {"_value" : "Biography information for Richard Burden"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Northfield"}
, "tablingMemberPrinted" : [{"_value" : "Richard Burden"}
], "uin" : "221587"}
, {"_about" : "http://data.parliament.uk/resources/1055821", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1055821/answer", "answerText" : {"_value" : " Improving care for people who suffer stroke, and preventing strokes, are priorities for the National Health Service as set out in the recently published NHS Long Term Plan. Building on the learning and success of the previous National Stroke strategy, NHS England will work with partners across the system to lead a programme which will drive the next step change in the care stroke patients receive. As well as significant investment in early cardiovascular disease detection and prevention, this will include funding major increases in the number of patients benefitting from potentially life-changing treatment to dissolve or remove blood clots. Further investment in higher intensity models for stroke rehabilitation will ensure patients have the best chance of returning to employment or independence, experiencing reduced disability and improved support for cognitive and psychological need.<\/p> <\/p> Further information on funding will be set out in the implementation framework for the Long Term Plan, due to be published in the spring.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-02-14", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-14T17:30:56.187Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-02-06", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Strokes: Health Services"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how much funding his Department has allocated to the development of a national stroke plan.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/301", "label" : {"_value" : "Biography information for Richard Burden"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Northfield"}
, "tablingMemberPrinted" : [{"_value" : "Richard Burden"}
], "uin" : "217450"}
, {"_about" : "http://data.parliament.uk/resources/1050512", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1050512/answer", "answerText" : {"_value" : " Guidance issued to all National Health Service trusts, pharmacies and general practices by the Department and NHS England has informed them of our plans for ensuring continuity of supply of medicines and advised them that they can expect to be able to continue accessing medicines through their existing supply routes in the event of a \u2018no deal\u2019 European Union exit. General practitioners (GPs) and providers should continue to prescribe medicines and other medical products as normal.<\/p> <\/p> On 23 August 2018, my Rt. hon. Friend the Secretary of State for Health and Social Care sent a letter to NHS England outlining preparations for the EU Exit, including in relation to General Practice. On 21 December 2018, the EU Exit Operational Guidance for the Health and Social Care system, including GPs, was issued. On 18 January 2019, a joint letter from the Department and NHS England from chief pharmacist, Keith Ridge, was sent to GPs, pharmacists and senior leaders within the NHS.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
}
, "answeringMemberConstituency" : {"_value" : "Wimbledon"}
, "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
, "dateOfAnswer" : {"_value" : "2019-02-06", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-02-06T17:09:00.473Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-01-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Drugs"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that GP surgeries are supplied with adequate guidance for patients on their medication in the event that the UK leaves the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/301", "label" : {"_value" : "Biography information for Richard Burden"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Northfield"}
, "tablingMemberPrinted" : [{"_value" : "Richard Burden"}
], "uin" : "213939"}
, {"_about" : "http://data.parliament.uk/resources/1023974", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1023974/answer", "answerText" : {"_value" : " The information requested is attached. It is taken from the Improving Access to Psychological Therapies (IAPT) dataset held by NHS Digital.<\/p> <\/p> The data shows that waiting times for IAPT services for people with post-traumatic stress disorder are decreasing both nationally and in West Midlands clinical commissioning groups.<\/p> <\/p> Improving Access to Psychological Therapies (IAPT) is a National Health Service programme that offers a range of National Institute for Health and Care Excellence-approved therapies for treating people with depression or anxiety.<\/p> <\/p> All historical IAPT publications, including annual data, are available at the following link:<\/p> <\/p> http://www.digital.nhs.uk/iaptreports<\/a><\/p> <\/p> Further information about the IAPT dataset is available at the following link:<\/p> <\/p> http://www.digital.nhs.uk/iapt<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4065", "label" : {"_value" : "Biography information for Dame Jackie Doyle-Price"}
}
, "answeringMemberConstituency" : {"_value" : "Thurrock"}
, "answeringMemberPrinted" : {"_value" : "Jackie Doyle-Price"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/1023974/answer/attachment/1", "fileName" : {"_value" : "Data PQ201564 and PQ201573 (002).xlsx"}
, "title" : "PQ201564,PQ201573 attached data"}
, "dateOfAnswer" : {"_value" : "2018-12-18", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "201573"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2018-12-18T14:27:57.68Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2018-12-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Post-traumatic Stress Disorder"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what information his Department holds on average waiting times for access to psychological therapies for patients with post-traumatic stress disorder in (a) Birmingham, (b) the West Midlands and (c) England.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/301", "label" : {"_value" : "Biography information for Richard Burden"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Northfield"}
, "tablingMemberPrinted" : [{"_value" : "Richard Burden"}
], "uin" : "201564"}
, {"_about" : "http://data.parliament.uk/resources/1023975", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1023975/answer", "answerText" : {"_value" : " The information requested is attached. It is taken from the Improving Access to Psychological Therapies (IAPT) dataset held by NHS Digital.<\/p> <\/p> The data shows that waiting times for IAPT services for people with post-traumatic stress disorder are decreasing both nationally and in West Midlands clinical commissioning groups.<\/p> <\/p> Improving Access to Psychological Therapies (IAPT) is a National Health Service programme that offers a range of National Institute for Health and Care Excellence-approved therapies for treating people with depression or anxiety.<\/p> <\/p> All historical IAPT publications, including annual data, are available at the following link:<\/p> <\/p> http://www.digital.nhs.uk/iaptreports<\/a><\/p> <\/p> Further information about the IAPT dataset is available at the following link:<\/p> <\/p>
Month<\/p><\/td> | Number of patients started treatment by week since referral<\/p><\/td> | Total number of completed pathways (all)<\/p><\/td> | % within 2 weeks<\/p><\/td><\/tr> | |||
More than 0-2 weeks<\/p><\/td> | More than 2-6 weeks<\/p><\/td> | More than 6-12 weeks<\/p><\/td> | 12 weeks<\/p><\/td><\/tr> | |||
June 2017<\/p><\/td> | 873<\/p><\/td> | 193<\/p><\/td> | 39<\/p><\/td> | 22<\/p><\/td> | 1,127<\/p><\/td> | 77.50%<\/p><\/td><\/tr> |
July 2017<\/p><\/td> | 824<\/p><\/td> | 226<\/p><\/td> | 36<\/p><\/td> | 14<\/p><\/td> | 1,100<\/p><\/td> | 74.90%<\/p><\/td><\/tr> |
August 2017<\/p><\/td> | 816<\/p><\/td> | 207<\/p><\/td> | 45<\/p><\/td> | 16<\/p><\/td> | 1,084<\/p><\/td> | 75.30%<\/p><\/td><\/tr> |
September 2017<\/p><\/td> | 818<\/p><\/td> | 187<\/p><\/td> | 47<\/p><\/td> | 15<\/p><\/td> | 1,067<\/p><\/td> | 76.70%<\/p><\/td><\/tr> |
October 2017<\/p><\/td> | 836<\/p><\/td> | 178<\/p><\/td> | 50<\/p><\/td> | 18<\/p><\/td> | 1,082<\/p><\/td> | 77.30%<\/p><\/td><\/tr> |
November 2017<\/p><\/td> | 787<\/p><\/td> | 230<\/p><\/td> | 50<\/p><\/td> | 22<\/p><\/td> | 1,089<\/p><\/td> | 72.30%<\/p><\/td><\/tr> |
December 2017<\/p><\/td> | 699<\/p><\/td> | 198<\/p><\/td> | 39<\/p><\/td> | 19<\/p><\/td> | 955<\/p><\/td> | 73.20%<\/p><\/td><\/tr> |
January 2018<\/p><\/td> | 722<\/p><\/td> | 238<\/p><\/td> | 65<\/p><\/td> | 17<\/p><\/td> | 1042<\/p><\/td> | 69.30%<\/p><\/td><\/tr> |
February 2018<\/p><\/td> | 807<\/p><\/td> | 185<\/p><\/td> | 36<\/p><\/td> | 24<\/p><\/td> | 1,052<\/p><\/td> | 76.70%<\/p><\/td><\/tr> |
March 18<\/p><\/td> | 795<\/p><\/td> | 178<\/p><\/td> | 49<\/p><\/td> | 26<\/p><\/td> | 1,048<\/p><\/td> | 75.90%<\/p><\/td><\/tr> |
April 2018<\/p><\/td> | 783<\/p><\/td> | 204<\/p><\/td> | 44<\/p><\/td> | 21<\/p><\/td> | 1,052<\/p><\/td> | 74.40%<\/p><\/td><\/tr> |
May 2018<\/p><\/td> | 840<\/p><\/td> | 210<\/p><\/td> | 47<\/p><\/td> | 12<\/p><\/td> | 1,109<\/p><\/td> | 75.70%<\/p><\/td><\/tr><\/tbody><\/table> <\/p> Information for people in Birmingham is not available in the format requested. The number of patients who started treatment for Early Intervention in Psychosis and waited less than 2 weeks are displayed for clinical commissioning groups (CCGs) that cover Birmingham for last 12 months of published data, which cover June 2017 to May 2018. These CCGs are:<\/p> <\/p> - NHS Birmingham Cross City CCG (until March 2018);<\/p> - NHS Birmingham South and Central CCG (until March 2018);<\/p> - NHS Birmingham and Solihull CCG (since April 2018); and<\/p> - NHS Sandwell and West Birmingham CCG (all 12 months).<\/p> <\/p> From April this year there are only two CCGs for Birmingham: NHS Birmingham and Solihull and NHS Sandwell and West Birmingham CCGs.<\/p> <\/p> These figures are attached and can be accessed in the monthly files at the following link:<\/p> <\/p> |